This protocol describes the establishment of angiogenesis models stimulated by fibroblast growth factor 2 (FGF2, also termed bFGF). The models are intended for assessing pro-angiogenic activity, screening inhibitors, dissecting FGFR downstream signaling, and interrogating matrix-dependent ...